The Corus CAD Gene Expression Test Can Help Commercial Health Plans Reduce Costs by Improving the Accuracy of the Diagnostic Workup in Patients with Suspected Obstructive Coronary Artery Disease by longitudeadmin | Feb 26, 2014 | Portfolio News
Amarin Announces FDA Award of Three-Year Exclusivity for Vascepa® (icosapent ethyl) Capsules by longitudeadmin | Feb 21, 2014 | Portfolio News
Jazz Pharmaceuticals Announces U.S. Commercial Availability Of Versacloz™ (clozapine, USP) Oral Suspension by longitudeadmin | Feb 11, 2014 | Portfolio News
Mallinckrodt plc to Acquire Cadence Pharmaceuticals, Inc. for $14.00 Per Share, in Cash by longitudeadmin | Feb 11, 2014 | Portfolio News
Jazz Pharmaceuticals Breaks Ground On New Manufacturing And Development Facility In Ireland by longitudeadmin | Feb 10, 2014 | Portfolio News
